[Documentation]
information1 = This file stores the OID assignments for resources defined in this IG.
information2 = It must be added to git and committed when resources are added or their id is changed
information3 = You should not generally need to edit this file, but if you do:
information4 =  (a) you can change the id of a resource (left side) if you change it's actual id in your source, to maintain OID consistency
information5 =  (b) you can change the oid of the resource to an OID you assign manually. If you really know what you're doing with OIDs
information6 = There is never a reason to edit anything else

[Key]
CodeSystem = 1
ValueSet = 98
ConceptMap = 1
StructureDefinition = 65
OperationDefinition = 1
SearchParameter = 1
CapabilityStatement = 10

[CodeSystem]
snomed-requested-cs = 2.16.840.1.113883.4.642.40.15.16.1

[ValueSet]
mcode-all-risk-assessment-value-vs = 2.16.840.1.113883.4.642.40.15.48.1
mcode-benign-uncertain-neoplasm-brain-cns-disorder-vs = 2.16.840.1.113883.4.642.40.15.48.2
mcode-binet-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.3
mcode-body-location-and-laterality-qualifier-vs = 2.16.840.1.113883.4.642.40.15.48.4
mcode-body-location-qualifier-vs = 2.16.840.1.113883.4.642.40.15.48.5
mcode-brachytherapy-high-dose-rate-electronic-technique-vs = 2.16.840.1.113883.4.642.40.15.48.6
mcode-brachytherapy-high-dose-rate-technique-vs = 2.16.840.1.113883.4.642.40.15.48.7
mcode-brachytherapy-low-dose-rate-temporary-technique-vs = 2.16.840.1.113883.4.642.40.15.48.8
mcode-brachytherapy-modality-vs = 2.16.840.1.113883.4.642.40.15.48.9
mcode-brachytherapy-permanent-seeds-technique-vs = 2.16.840.1.113883.4.642.40.15.48.10
mcode-brachytherapy-pulsed-dose-rate-technique-vs = 2.16.840.1.113883.4.642.40.15.48.11
mcode-brachytherapy-radiopharmaceutical-technique-vs = 2.16.840.1.113883.4.642.40.15.48.12
mcode-brachytherapy-technique-vs = 2.16.840.1.113883.4.642.40.15.48.13
mcode-breslow-depth-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.14
mcode-cancer-body-location-vs = 2.16.840.1.113883.4.642.40.15.48.15
mcode-cancer-disease-status-evidence-type-vs = 2.16.840.1.113883.4.642.40.15.48.16
mcode-cancer-disorder-vs = 2.16.840.1.113883.4.642.40.15.48.17
mcode-cancer-related-surgical-procedure-vs = 2.16.840.1.113883.4.642.40.15.48.18
mcode-cancer-stage-type-vs = 2.16.840.1.113883.4.642.40.15.48.19
mcode-cancer-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.20
mcode-cancer-staging-method-vs = 2.16.840.1.113883.4.642.40.15.48.21
mcode-carcinoma-in-situ-disorder-vs = 2.16.840.1.113883.4.642.40.15.48.22
mcode-clark-level-value-vs = 2.16.840.1.113883.4.642.40.15.48.23
mcode-clin-or-path-modifier-vs = 2.16.840.1.113883.4.642.40.15.48.24
mcode-condition-status-trend-max-vs = 2.16.840.1.113883.4.642.40.15.48.25
mcode-condition-status-trend-vs = 2.16.840.1.113883.4.642.40.15.48.26
mcode-cytologic-evidence-malignancy-vs = 2.16.840.1.113883.4.642.40.15.48.27
mcode-deauville-scale-vs = 2.16.840.1.113883.4.642.40.15.48.28
mcode-fab-classification-value-vs = 2.16.840.1.113883.4.642.40.15.48.29
mcode-figo-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.30
mcode-figo-staging-method-vs = 2.16.840.1.113883.4.642.40.15.48.31
mcode-gleason-grade-group-value-vs = 2.16.840.1.113883.4.642.40.15.48.32
mcode-histologic-behavior-and-type-vs = 2.16.840.1.113883.4.642.40.15.48.33
mcode-histologic-grade-vs = 2.16.840.1.113883.4.642.40.15.48.34
mcode-histologic-grading-system-vs = 2.16.840.1.113883.4.642.40.15.48.35
mcode-histology-morphology-behavior-vs = 2.16.840.1.113883.4.642.40.15.48.36
mcode-history-of-metastatic-malignant-neoplasm-vs = 2.16.840.1.113883.4.642.40.15.48.37
mcode-human-specimen-type-vs = 2.16.840.1.113883.4.642.40.15.48.38
mcode-hypereosinophilic-syndrome-disorder-vs = 2.16.840.1.113883.4.642.40.15.48.39
mcode-lansky-play-performance-vs = 2.16.840.1.113883.4.642.40.15.48.40
mcode-laterality-qualifier-vs = 2.16.840.1.113883.4.642.40.15.48.41
mcode-lymphoma-stage-bulky-modifier-vs = 2.16.840.1.113883.4.642.40.15.48.42
mcode-lymphoma-stage-value-modifier-vs = 2.16.840.1.113883.4.642.40.15.48.43
mcode-lymphoma-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.44
mcode-lymphoma-staging-method-vs = 2.16.840.1.113883.4.642.40.15.48.45
mcode-melanoma-in-situ-disorder-vs = 2.16.840.1.113883.4.642.40.15.48.46
mcode-myeloma-iss-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.47
mcode-myeloma-riss-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.48
mcode-neuroblastoma-INRGSS-value-vs = 2.16.840.1.113883.4.642.40.15.48.49
mcode-neuroblastoma-inss-value-vs = 2.16.840.1.113883.4.642.40.15.48.50
mcode-normalization-basis-vs = 2.16.840.1.113883.4.642.40.15.48.51
mcode-primary-cancer-disorder-vs = 2.16.840.1.113883.4.642.40.15.48.52
mcode-primary-malignant-neoplasm-disorder-vs = 2.16.840.1.113883.4.642.40.15.48.53
mcode-procedure-intent-vs = 2.16.840.1.113883.4.642.40.15.48.54
mcode-radiotherapy-modality-vs = 2.16.840.1.113883.4.642.40.15.48.55
mcode-radiotherapy-technique-vs = 2.16.840.1.113883.4.642.40.15.48.56
mcode-radiotherapy-treatment-location-qualifier-vs = 2.16.840.1.113883.4.642.40.15.48.57
mcode-radiotherapy-treatment-location-vs = 2.16.840.1.113883.4.642.40.15.48.58
mcode-radiotherapy-volume-type-vs = 2.16.840.1.113883.4.642.40.15.48.59
mcode-rai-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.60
mcode-rai-staging-method-vs = 2.16.840.1.113883.4.642.40.15.48.61
mcode-rhabdomyosarcoma-assessment-value-vs = 2.16.840.1.113883.4.642.40.15.48.62
mcode-rhabdomyosarcoma-clinical-group-value-vs = 2.16.840.1.113883.4.642.40.15.48.63
mcode-risk-assessment-type-vs = 2.16.840.1.113883.4.642.40.15.48.64
mcode-risk-assessment-vs = 2.16.840.1.113883.4.642.40.15.48.65
mcode-secondary-cancer-disorder-vs = 2.16.840.1.113883.4.642.40.15.48.66
mcode-teleradiotherapy-carbon-ion-beam-technique-vs = 2.16.840.1.113883.4.642.40.15.48.67
mcode-teleradiotherapy-electron-beam-technique-vs = 2.16.840.1.113883.4.642.40.15.48.68
mcode-teleradiotherapy-modality-vs = 2.16.840.1.113883.4.642.40.15.48.69
mcode-teleradiotherapy-neutron-beam-technique-vs = 2.16.840.1.113883.4.642.40.15.48.70
mcode-teleradiotherapy-photon-beam-technique-vs = 2.16.840.1.113883.4.642.40.15.48.71
mcode-teleradiotherapy-proton-beam-technique-vs = 2.16.840.1.113883.4.642.40.15.48.72
mcode-teleradiotherapy-technique-vs = 2.16.840.1.113883.4.642.40.15.48.73
mcode-tnm-distant-metastases-category-max-vs = 2.16.840.1.113883.4.642.40.15.48.74
mcode-tnm-distant-metastases-category-vs = 2.16.840.1.113883.4.642.40.15.48.75
mcode-tnm-distant-metastases-staging-type-max-vs = 2.16.840.1.113883.4.642.40.15.48.76
mcode-tnm-distant-metastases-staging-type-vs = 2.16.840.1.113883.4.642.40.15.48.77
mcode-tnm-primary-tumor-category-max-vs = 2.16.840.1.113883.4.642.40.15.48.78
mcode-tnm-primary-tumor-category-vs = 2.16.840.1.113883.4.642.40.15.48.79
mcode-tnm-primary-tumor-staging-type-max-vs = 2.16.840.1.113883.4.642.40.15.48.80
mcode-tnm-primary-tumor-staging-type-vs = 2.16.840.1.113883.4.642.40.15.48.81
mcode-tnm-regional-nodes-category-max-vs = 2.16.840.1.113883.4.642.40.15.48.82
mcode-tnm-regional-nodes-category-vs = 2.16.840.1.113883.4.642.40.15.48.83
mcode-tnm-regional-nodes-staging-type-max-vs = 2.16.840.1.113883.4.642.40.15.48.84
mcode-tnm-regional-nodes-staging-type-vs = 2.16.840.1.113883.4.642.40.15.48.85
mcode-tnm-stage-group-max-vs = 2.16.840.1.113883.4.642.40.15.48.86
mcode-tnm-stage-group-staging-type-max-vs = 2.16.840.1.113883.4.642.40.15.48.87
mcode-tnm-stage-group-staging-type-vs = 2.16.840.1.113883.4.642.40.15.48.88
mcode-tnm-stage-group-vs = 2.16.840.1.113883.4.642.40.15.48.89
mcode-tnm-staging-method-vs = 2.16.840.1.113883.4.642.40.15.48.90
mcode-treatment-termination-reason-vs = 2.16.840.1.113883.4.642.40.15.48.91
mcode-tumor-marker-test-vs = 2.16.840.1.113883.4.642.40.15.48.92
mcode-tumor-morphology-code-max-vs = 2.16.840.1.113883.4.642.40.15.48.93
mcode-tumor-morphology-code-vs = 2.16.840.1.113883.4.642.40.15.48.94
mcode-tumor-size-method-vs = 2.16.840.1.113883.4.642.40.15.48.95
mcode-tumor-size-units-vs = 2.16.840.1.113883.4.642.40.15.48.96
mcode-wilms-tumor-body-site-vsCOG = 2.16.840.1.113883.4.642.40.15.48.97
mcode-wilms-tumor-stage-value-vs = 2.16.840.1.113883.4.642.40.15.48.98

[ConceptMap]
TG263CM = 2.16.840.1.113883.4.642.40.15.18.1

[StructureDefinition]
mcode-ALL-risk-assessment = 2.16.840.1.113883.4.642.40.15.42.1
mcode-body-location-qualifier = 2.16.840.1.113883.4.642.40.15.42.2
mcode-body-structure-identifier = 2.16.840.1.113883.4.642.40.15.42.3
mcode-body-surface-area = 2.16.840.1.113883.4.642.40.15.42.4
mcode-cancer-disease-status-evidence-type = 2.16.840.1.113883.4.642.40.15.42.5
mcode-cancer-disease-status = 2.16.840.1.113883.4.642.40.15.42.6
mcode-cancer-patient = 2.16.840.1.113883.4.642.40.15.42.7
mcode-cancer-related-medication-administration = 2.16.840.1.113883.4.642.40.15.42.8
mcode-cancer-related-medication-request = 2.16.840.1.113883.4.642.40.15.42.9
mcode-cancer-related-surgical-procedure = 2.16.840.1.113883.4.642.40.15.42.10
mcode-cancer-risk-assessment = 2.16.840.1.113883.4.642.40.15.42.11
mcode-cancer-stage = 2.16.840.1.113883.4.642.40.15.42.12
mcode-cll-binet-stage = 2.16.840.1.113883.4.642.40.15.42.13
mcode-cll-rai-stage = 2.16.840.1.113883.4.642.40.15.42.14
mcode-comorbidities = 2.16.840.1.113883.4.642.40.15.42.15
mcode-deauville-scale = 2.16.840.1.113883.4.642.40.15.42.16
mcode-ecog-performance-status = 2.16.840.1.113883.4.642.40.15.42.17
mcode-genomic-region-studied = 2.16.840.1.113883.4.642.40.15.42.18
mcode-genomic-variant = 2.16.840.1.113883.4.642.40.15.42.19
mcode-genomics-report = 2.16.840.1.113883.4.642.40.15.42.20
mcode-gynecologic-tumor-figo-stage = 2.16.840.1.113883.4.642.40.15.42.21
mcode-histologic-behavior-and-type = 2.16.840.1.113883.4.642.40.15.42.22
mcode-histologic-grade = 2.16.840.1.113883.4.642.40.15.42.23
mcode-histology-morphology-behavior = 2.16.840.1.113883.4.642.40.15.42.24
mcode-history-of-metastatic-cancer = 2.16.840.1.113883.4.642.40.15.42.25
mcode-human-specimen = 2.16.840.1.113883.4.642.40.15.42.26
mcode-karnofsky-performance-status = 2.16.840.1.113883.4.642.40.15.42.27
mcode-lansky-play-performance-status = 2.16.840.1.113883.4.642.40.15.42.28
mcode-laterality-qualifier = 2.16.840.1.113883.4.642.40.15.42.29
mcode-lymphoma-stage = 2.16.840.1.113883.4.642.40.15.42.30
mcode-melanoma-breslow-depth-stage = 2.16.840.1.113883.4.642.40.15.42.31
mcode-melanoma-clark-level = 2.16.840.1.113883.4.642.40.15.42.32
mcode-myeloma-iss-stage = 2.16.840.1.113883.4.642.40.15.42.33
mcode-myeloma-riss-stage = 2.16.840.1.113883.4.642.40.15.42.34
mcode-neuroblastoma-inrgss-stage = 2.16.840.1.113883.4.642.40.15.42.35
mcode-neuroblastoma-inss-stage = 2.16.840.1.113883.4.642.40.15.42.36
mcode-normalization-basis = 2.16.840.1.113883.4.642.40.15.42.37
mcode-patient-bundle = 2.16.840.1.113883.4.642.40.15.42.38
mcode-patient-group = 2.16.840.1.113883.4.642.40.15.42.39
mcode-primary-cancer-condition = 2.16.840.1.113883.4.642.40.15.42.40
mcode-procedure-intent = 2.16.840.1.113883.4.642.40.15.42.41
mcode-prostate-gleason-grade-group = 2.16.840.1.113883.4.642.40.15.42.42
mcode-radiotherapy-course-summary = 2.16.840.1.113883.4.642.40.15.42.43
mcode-radiotherapy-dose-delivered-to-volume = 2.16.840.1.113883.4.642.40.15.42.44
mcode-radiotherapy-modality-and-technique = 2.16.840.1.113883.4.642.40.15.42.45
mcode-radiotherapy-modality = 2.16.840.1.113883.4.642.40.15.42.46
mcode-radiotherapy-sessions = 2.16.840.1.113883.4.642.40.15.42.47
mcode-radiotherapy-technique = 2.16.840.1.113883.4.642.40.15.42.48
mcode-radiotherapy-volume = 2.16.840.1.113883.4.642.40.15.42.49
mcode-related-condition-absent = 2.16.840.1.113883.4.642.40.15.42.50
mcode-related-condition = 2.16.840.1.113883.4.642.40.15.42.51
mcode-rhabdomyosarcoma-clinical-group-stage = 2.16.840.1.113883.4.642.40.15.42.52
mcode-rhabdomyosarcoma-risk-assessment = 2.16.840.1.113883.4.642.40.15.42.53
mcode-secondary-cancer-condition = 2.16.840.1.113883.4.642.40.15.42.54
mcode-tnm-category = 2.16.840.1.113883.4.642.40.15.42.55
mcode-tnm-distant-metastases-category = 2.16.840.1.113883.4.642.40.15.42.56
mcode-tnm-primary-tumor-category = 2.16.840.1.113883.4.642.40.15.42.57
mcode-tnm-regional-nodes-category = 2.16.840.1.113883.4.642.40.15.42.58
mcode-tnm-stage-group = 2.16.840.1.113883.4.642.40.15.42.59
mcode-treatment-termination-reason = 2.16.840.1.113883.4.642.40.15.42.60
mcode-tumor-marker-test = 2.16.840.1.113883.4.642.40.15.42.61
mcode-tumor-morphology = 2.16.840.1.113883.4.642.40.15.42.62
mcode-tumor-size = 2.16.840.1.113883.4.642.40.15.42.63
mcode-tumor = 2.16.840.1.113883.4.642.40.15.42.64
mcode-wilms-tumor-stage = 2.16.840.1.113883.4.642.40.15.42.65

[OperationDefinition]
mcode-patient-everything = 2.16.840.1.113883.4.642.40.15.33.1

[SearchParameter]
Condition-code = 2.16.840.1.113883.4.642.40.15.40.1

[CapabilityStatement]
mcode-receiver-cancer-conditions-then-patients = 2.16.840.1.113883.4.642.40.15.13.1
mcode-receiver-patient-bundle = 2.16.840.1.113883.4.642.40.15.13.2
mcode-receiver-patients-and-cancer-conditions = 2.16.840.1.113883.4.642.40.15.13.3
mcode-receiver-patients-in-group = 2.16.840.1.113883.4.642.40.15.13.4
mcode-receiver-patients-with-cancer-condition = 2.16.840.1.113883.4.642.40.15.13.5
mcode-sender-cancer-conditions-then-patients = 2.16.840.1.113883.4.642.40.15.13.6
mcode-sender-patient-bundle = 2.16.840.1.113883.4.642.40.15.13.7
mcode-sender-patients-and-cancer-conditions = 2.16.840.1.113883.4.642.40.15.13.8
mcode-sender-patients-in-group = 2.16.840.1.113883.4.642.40.15.13.9
mcode-sender-patients-with-cancer-condition = 2.16.840.1.113883.4.642.40.15.13.10

